These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 15299062)

  • 21. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation therapy and radio-nuclides for palliation of bone pain.
    Crook J
    Urol Clin North Am; 2006 May; 33(2):219-26, vii. PubMed ID: 16631460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of palliative and symptomatic radiotherapy in bone metastasis].
    Tordiglione M; Luraghi R; Antognoni P
    Radiol Med; 1999 May; 97(5):372-7. PubMed ID: 10432969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can response to palliative treatment with radiopharmaceuticals be further enhanced?
    Zafeirakis A
    Hell J Nucl Med; 2009; 12(2):151-7. PubMed ID: 19675870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Painful boney metastases.
    Smith HS; Barkin RL
    Am J Ther; 2014; 21(2):106-30. PubMed ID: 23344095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 177Lu-EDTMP: a potential therapeutic bone agent.
    Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
    Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.
    Tomblyn M
    Cancer Control; 2012 Apr; 19(2):137-44. PubMed ID: 22487976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 186Re-HEDP for metastatic bone pain in breast cancer patients.
    Lam MG; de Klerk JM; van Rijk PP
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
    Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
    J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
    Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
    J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
    Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
    Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of rhenium-188 HEDP in bone metastases therapy.
    Scheffler J; Derejko M; Bandurski T; Romanowicz G
    Nucl Med Rev Cent East Eur; 2003; 6(1):55-7. PubMed ID: 14600935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.
    Kolesnikov-Gauthier H; Carpentier P; Depreux P; Vennin P; Caty A; Sulman C
    J Nucl Med; 2000 Oct; 41(10):1689-94. PubMed ID: 11037999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of palliative external beam radiation therapy in boney metastases pain management.
    Cai B; Nickman NA; Gaffney DK
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):28-34. PubMed ID: 23394451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and Strontium-89.
    De Ruysscher D; Spaas P; Specenier P
    Acta Urol Belg; 1996 Sep; 64(3):13-9. PubMed ID: 8946776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radionuclide therapy for painful bone metastases].
    Szefer J; Zuchora Z
    Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nuclear medicine pain therapy in osseous metastases of prostate cancer].
    Müller S; Rembrink K; Reiners C
    Urologe A; 1993 Mar; 32(2):121-7. PubMed ID: 7682742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies on the potential use of
    Zakaly HMH; Mostafa MYA; Deryabina D; Zhukovsky M
    Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.
    Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S
    J BUON; 2009; 14(2):245-9. PubMed ID: 19650174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.